Avenue Therapeutics: Nasdaq Granted Extension for Compliance to Continued Listing Through May 20 >ATXI
Avenue Therapeutics: Nasdaq Granted Extension for Compliance to Continued Listing Through May 20 >ATXI
Avenue Therapeutics:纳斯达克批准将合规性延期至5月20日 >ATXI
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册